[DPRX] Dipexium Pharmaceuticals, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 2 Change: 0.4 (25%)
Ext. hours: 2.05 Change: 0.05 (2.5%)

chart DPRX

Refresh chart

Description: Dipexium Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of antibiotics for the treatment of infectious diseases. It develops Locilex (pexiganan cream 0.8%), a novel, broad spectrum, and topical antibiotic, which is in phase 3 clinical trials for the treatment of mild infections of diabetic foot ulcers. The company was founded in 2010 and is based in New York, New York.

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-62.96% ROE-64.83% ROI
Current Ratio34.57 Quick Ratio Long Term Debt/Equity Debt Ratio0.03
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities Cash From Investing Activities Cash From Operating Activities-3.04 M Gross Profit
Net Profit-4.19 M Operating Profit-4.19 M Total Assets24.18 M Total Current Assets24.13 M
Total Current Liabilities700 K Total Debt Total Liabilities700 K Total Revenue
Technical Data
High 52 week16.5 Low 52 week1.1 Last close1.34 Last change0%
RSI40.83 Average true range0.15 Beta0.28 Volume6.94 M
Simple moving average 20 days1.16% Simple moving average 50 days3.55% Simple moving average 200 days-75.65%
Performance Data
Performance Week0% Performance Month2.92% Performance Quart-10.8% Performance Half-43.06%
Performance Year-89.25% Performance Year-to-date-16.38% Volatility daily4.26% Volatility weekly9.54%
Volatility monthly19.54% Volatility yearly67.7% Relative Volume3996.42% Average Volume94.65 K
New High New Low

News

2017-04-24 09:20:13 | Houston real estate, energy, pharma cos. close more than $2B in deals

2017-04-18 05:00:44 | Dipexium Pharmaceuticals posts 1Q loss

2017-02-14 07:30:00 | PLx Pharma Announces Publication of Positive Antiplatelet Data for Aspertec in Peer-Reviewed Medical Journal JACC

2017-01-26 13:04:06 | DIPEXIUM PHARMACEUTICALS, INC. Financials

2017-01-25 17:36:00 | SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Dipexium Pharma - DPRX

2017-01-20 16:13:20 | DIPEXIUM PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report

2016-12-22 17:56:39 | Dipexium shares surge on announced merger with PLx Pharma

2016-12-22 16:51:26 | DIPEXIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Changes in Control or

2016-12-22 16:48:14 | Dipexium and PLx Pharma Announce Merger Agreement

2016-12-22 16:40:00 | 4:40 pm Dipexium Pharmaceuticals announces merger with PLx Pharma shares halted

2016-12-22 16:39:00 | Dipexium and PLx Pharma Announce Merger Agreement

2016-12-14 16:06:47 | DIPEXIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements an

2016-12-14 01:34:51 | Is Dipexium Pharmaceuticals Inc DPRX A Good Stock To Buy?

2016-11-16 16:06:40 | DIPEXIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers

2016-11-10 07:11:23 | Dipexium Pharmaceuticals posts 3Q loss

2016-11-10 07:11:07 | Dipexium Pharmaceuticals Reports Third Quarter 2016 Financial Results

2016-11-10 07:00:00 | Dipexium Pharmaceuticals Reports Third Quarter 2016 Financial Results

2016-11-09 16:09:29 | DIPEXIUM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report

2016-10-31 16:08:02 | DIPEXIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits

2016-10-29 09:45:55 | 6 Companies That Destroyed Shareholders Last Week

2016-10-26 08:15:00 | Blog Coverage Dipexium Stock Tanks on Trial Failure

2016-10-25 16:09:00 | Is This the Beginning of the End of a Dipexium Implosion?

2016-10-25 16:07:00 | Dipexium Foot Ulcer Study Fails Big Time DPRX

2016-10-25 16:04:01 | Ericsson, Nike Drop in on Tuesday’s 52-Week Low Club

2016-10-25 12:32:35 | Blackberry BBRY’s Swan Song, Bear Attacks and Failed Drugs: 5 Stocks Getting Mauled by the Market Today

2016-10-25 11:35:56 | Dipexium Pharmaceuticals downgraded by Feltl & Co.

2016-10-25 08:22:22 | Dipexium's stock plunges in active trade after trial fails trials

2016-10-25 07:11:09 | Dipexium Announces Top-line Data from OneStep Phase 3 Trials with Locilex® in Mild Diabetic Foot Infection Did Not Meet Primary Clinical Endpoint of Superiority Versus Vehicle Plus Standardized Wound Care

2016-10-25 07:00:00 | Dipexium Announces Top-line Data from OneStep Phase 3 Trials with Locilex® in Mild Diabetic Foot Infection Did Not Meet Primary Clinical Endpoint of Superiority Versus Vehicle Plus Standardized Wound Care

2016-10-20 07:08:09 | Dipexium Provides Update on Availability of Results from Pivotal Phase 3 Clinical Trials with Locilex®

2016-10-20 07:00:00 | Dipexium Provides Update on Availability of Results from Pivotal Phase 3 Clinical Trials with Locilex®

2016-10-04 08:48:02 | Dipexium Receives European Medicines Agency Designation as a Small and Medium Enterprise

2016-10-04 08:00:00 | Dipexium Receives European Medicines Agency Designation as a Small and Medium Enterprise

2016-09-28 08:45:12 | Dipexium Pharmaceuticals DPRX Worth a Look: Stock Up 8.8%

2016-09-16 12:41:03 | Dipexium Pharmaceuticals, Inc. :DPRX-US: Earnings Analysis: Q2, 2016 By the Numbers : September 16, 2016

2016-09-07 08:09:10 | Dipexium Pharmaceuticals Announces Issuance of Locilex® Patent by European Union

2016-09-07 08:00:00 | Dipexium Pharmaceuticals Announces Issuance of Locilex® Patent by European Union

2016-09-01 08:45:12 | Dipexium Pharmaceuticals DPRX in Focus: Stock Gains 8.5%

2016-08-24 08:18:10 | Dipexium Pharmaceuticals Announces Participation in September Investor Conferences

2016-08-24 08:00:00 | Dipexium Pharmaceuticals Announces Participation in September Investor Conferences

2016-08-11 13:04:30 | DIPEXIUM PHARMACEUTICALS, INC. Financials

2016-08-04 07:22:16 | Dipexium Pharmaceuticals Reports Second Quarter 2016 Financial Results

2016-08-04 07:03:29 | Dipexium Pharmaceuticals posts 2Q loss

2016-08-04 07:00:00 | Dipexium Pharmaceuticals Reports Second Quarter 2016 Financial Results

2016-07-28 07:18:06 | Dipexium Pharmaceuticals to Hold Second Quarter 2016 Financial Results Conference Call on Thursday, August 4, 2016, at 8:30 a.m. ET

2016-07-28 07:00:00 | Dipexium Pharmaceuticals to Hold Second Quarter 2016 Financial Results Conference Call on Thursday, August 4, 2016, at 8:30 a.m. ET

2016-06-20 16:09:05 | Dipexium Pharmaceuticals' Locilex® Microbiology Data Presented at ASM Microbe 2016 Conference

2016-06-20 16:01:00 | Dipexium Pharmaceuticals' Locilex® Microbiology Data Presented at ASM Microbe 2016 Conference

2016-06-06 14:33:13 | Dipexium Pharmaceuticals, Inc. :DPRX-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016

2016-05-16 08:32:08 | Dipexium Announces Completion of Enrollment Objective in OneStep-1 Pivotal Phase 3 Clinical Trial